Skip to content

Physical Resilience: Indicators and Mechanisms in the Elderly (PRIME) Collaborative Phase 2

Physical Resilience: Indicators and Mechanisms in the Elderly (PRIME) Collaborative Phase 2

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04235309
Acronym
PRIME-Knee
Enrollment
297
Registered
2020-01-21
Start date
2020-02-27
Completion date
2023-10-30
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aging, Resilience

Brief summary

The purpose of this study is to examine underlying physical resilience (the ability to bounce back) in response to a specific stressor (total knee replacement).

Detailed description

In general, a person's specific resilience (ability to bounce back from a stressor) is thought to be dependent upon that person's specific biological and genetic makeup. However, these specific elements remain poorly understood. The purpose of this study is to identify important predictors and characteristics of resilience in response to a total knee replacement by examining baseline resilience (prior to surgery) and post-surgical resilience at multiple time points, allowing us to track resilience outcomes over time.

Interventions

None listed

Sponsors

National Institute on Aging (NIA)
CollaboratorNIH
Duke University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* 60 years of age or older * Ability to speak English * Planned elective knee replacement orthopedic surgery lasting 2 or more hours and requiring overnight observation or inpatient stay * Community dwelling

Exclusion criteria

* Unable to ambulate independently, with or without assistive device * Known dementia or screening 3MS score \<=77 * Inmate of a correctional facility (i.e. prisoners) * Active non-skin cancer or medical treatment for non-skin cancer with 12 months (chemotherapy, radiation, immunotherapy, hormonal therapy) * Vision or hearing impairment that, after best accommodation, prevents reliable cognitive assessment (visual/hearing) and/or precludes telephone interviews (hearing)

Design outcomes

Primary

MeasureTime frameDescription
Change in association between in vitro immune resiliency and resilient outcomes following elective orthopedic surgery.Baseline, Post-operative Day 1Whole blood samples containing PBMCs collected before/after surgery will be challenged with LPS and influenza vaccine to assess the cellular immune response using previously identified biomarkers of resiliency and RNA-seq analysis to identify novel biomarkers and molecular signatures.
Change in cognitive resiliency following orthopedic surgery as measured by 3D-CAM.Baseline, 1 weekScored as positive or negative. Positive indicates the presence of delirium.
Change in cognitive resiliency following orthopedic surgery as measured by cognitive change index (CCI) for patient.Baseline, 1 month, 2 months, 4 months, 6 monthsScores range from 20 - 100. Higher scores are associated with increased cognitive decline.
Change in cognitive resiliency following orthopedic surgery as measured by cognitive change index (CCI) for informant about patient.Baseline, 1 month, 2 months, 4 months, 6 monthsScores range from 20 - 100. Higher scores are associated with increased cognitive decline.
Change in musculoskeletal resiliency following orthopedic surgery as measured by physical activity (step counts)Baseline, 1 week, 1 month, 2 months, 4 months and 6 monthsAs measured by a Garmin device worn by participants
Change in musculoskeletal resiliency following orthopedic surgery as measured by Lower Extremity Physical Activities of Daily Living (LE PADLs)Baseline, 6 monthsScores are measured from 0 to 45. Higher scores are associated with more limited LE PADLs.
Change in musculoskeletal resiliency following orthopedic surgery as measured by PROMIS Pain IntensityBaseline, 1 week, 1 month, 2 months, 4 months and 6 monthsScores are measured from 3 to 15. Higher scores are associated with more intense pain.
Change in musculoskeletal resiliency following orthopedic surgery as measured by PROMIS Pain InterferenceBaseline, 1 week, 1 month, 2 months, 4 months and 6 monthsScores are measured from 6 to 30. Higher scores are associated with increased pain interference.

Secondary

MeasureTime frameDescription
Change in tissue oxygenation index (TOI)Baseline, 6 monthsMeasured using fNIRs (functional near infrared spectroscopy)
Intraoperative electrocardiography (ECG) RR variabilitySurgery up to three hoursMeasured as intra-operative ECG RR intervals collected from the heart monitor
Change in dual task gait speedBaseline, 6 monthsScore of combined walking and verbal fluency test

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026